Mining and influencing factors analysis of sacituzumab govitecan adverse drug event based on FAERS database
Common ADEs generally correspond with the prescribing information. Clinicians should be vigilant regarding unlisted ADEs about sacituzumab govitecan, and close monitoring of laboratory indicators ensure patient medication safety.
Authors
- Hua Peng (ORCID: https://orcid.org/0000-0001-5583-537X)
- Hao Fan (ORCID: https://orcid.org/0000-0002-4582-7250)
- Xuejiao Wu (ORCID: https://orcid.org/0000-0002-1116-6060)
- Yang Liu
- Xiaobo Liu (ORCID: https://orcid.org/0000-0001-5921-8491)
- Shuilin Wu (ORCID: https://orcid.org/0000-0001-6957-7498)
- Xueyu Duan
- Daoliang zhang
Institutions
- Xiaochang People's Hospital (CN)
- Hospital 463 People's Liberation Army (CN)
- Third People's Hospital of Yunnan Province (CN)
- Dali University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1080/14740338.2024.2430305
- Citations
- 1
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Yunnan Provincial Science and Technology Department